Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Clinical trial NCT00044291 · COMPLETED

Trial details

NCT number: NCT00044291
Sponsor: Intarcia Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Neoplasms, Hormone-dependent

Start date: 2002-06-01
Primary completion: 2006-01-01
Enrollment: 865

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.